ICHI: Bright Outlook in 2022 and Beyond
Analyst meeting came out with a positive tone. we expect 2022-24E earnings to continue to grow at 19%CAGR supported by new products launch and...
228 Views
ICHI: Terpene Products to Be the Key Highlight in 2Q21
We reiterate our BUY rating with a target price at Bt16.50, derived from 26.6xPE’21E which is equal to Asia-ex Japan consumer staple peer, slightly...
301 Views
ICHI: First Mover in Hemp-Related Products
Analyst meeting came out with positive tone. The company is expanding to hemp-related products in April 21. Meanwhile, introduction of new SKU will...
300 Views
ICHI: Healthy Earnings in 4Q20E and Fresh Outlook in 1H21
We reiterate our BUY rating with a target price at Bt13.50, derived from 24.7xPE’21E, which is ICHI’s 5-year trading average.
280 Views
ICHI: Fresh Outlook in 2021 Thanks to Functional Drinks
We reiterate our BUY rating with a new target price at Bt13.50 (from Bt10.10), derived from 24.7xPE’21E, which is ICHI’s 5-year trading average.
412 Views